- Home
- COEP vs IRIX Comparison
COEP vs IRIX Comparison
Compare COEP & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- IRIX
- Stock Information
- Founded
- COEP 2017
- IRIX 1989
- Country
- COEP United States
- IRIX United States
- Employees
- COEP N/A
- IRIX N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- COEP Health Care
- IRIX Health Care
- Exchange
- COEP Nasdaq
- IRIX Nasdaq
- Market Cap
- COEP 32.4M
- IRIX 27.5M
- IPO Year
- COEP N/A
- IRIX 1996
- Fundamental
- Price
- COEP $10.52
- IRIX $1.51
- Analyst Decision
- COEP
- IRIX Hold
- Analyst Count
- COEP 0
- IRIX 1
- Target Price
- COEP N/A
- IRIX $2.00
- AVG Volume (30 Days)
- COEP 109.2K
- IRIX 30.8K
- Earning Date
- COEP 03-25-2025
- IRIX 03-25-2025
- Dividend Yield
- COEP N/A
- IRIX N/A
- EPS Growth
- COEP N/A
- IRIX N/A
- EPS
- COEP N/A
- IRIX N/A
- Revenue
- COEP N/A
- IRIX $48,431,000.00
- Revenue This Year
- COEP N/A
- IRIX N/A
- Revenue Next Year
- COEP N/A
- IRIX $5.44
- P/E Ratio
- COEP N/A
- IRIX N/A
- Revenue Growth
- COEP N/A
- IRIX N/A
- 52 Week Low
- COEP $2.31
- IRIX $1.27
- 52 Week High
- COEP $13.70
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- COEP 48.65
- IRIX 38.42
- Support Level
- COEP $9.27
- IRIX $1.46
- Resistance Level
- COEP $12.95
- IRIX $1.60
- Average True Range (ATR)
- COEP 1.59
- IRIX 0.05
- MACD
- COEP -0.33
- IRIX -0.01
- Stochastic Oscillator
- COEP 38.56
- IRIX 18.75
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.